For: | Wang M, Busuttil RA, Pattison S, Neeson PJ, Boussioutas A. Immunological battlefield in gastric cancer and role of immunotherapies. World J Gastroenterol 2016; 22(28): 6373-6384 [PMID: 27605873 DOI: 10.3748/wjg.v22.i28.6373] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i28/6373.htm |
Number | Citing Articles |
1 |
Riccardo Dolcetti, Valli De Re. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 189 doi: 10.1007/978-3-030-04861-7_12
|
2 |
Emer Lynch, Austin G. Duffy, Ronan J. Kelly. Role of Immunotherapy in Gastroesophageal Cancers—Advances, Challenges and Future Strategies. Cancers 2023; 15(22): 5401 doi: 10.3390/cancers15225401
|
3 |
Yana Zavros. Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(1): 55 doi: 10.1016/j.jcmgh.2017.03.003
|
4 |
Yanzhen Bi, Quanyi Wang, Yonghong Yang, Quanquan Wang, Kai Zhang, Xiaobei Zhang, William C. Cho, Zhenfeng Shu, Jiannan Li, Lili Liu, Chuanping Si, Feng Hong. Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1893434
|
5 |
Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish R. Patel, Holbrook E.K. Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary L. Disis, Judith C. Kaiser, Martin A. Cheever, Howard Streicher, Steven P. Creekmore, Thomas A. Waldmann, Kevin C. Conlon. A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors. Clinical Cancer Research 2018; 24(7): 1525 doi: 10.1158/1078-0432.CCR-17-2451
|
6 |
Jun T. Low, Michael Christie, Matthias Ernst, Laure Dumoutier, Adele Preaudet, Yanhong Ni, Michael D.W. Griffin, Lisa A. Mielke, Andreas Strasser, Tracy L. Putoczki, Lorraine A. O’Reilly. Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of Signal Transducer and Activator of Transcription 1 to Promote Gastric Tumorigenesis in Mice. Gastroenterology 2020; 159(4): 1444 doi: 10.1053/j.gastro.2020.06.039
|
7 |
Jaqueline Ramalho Buttura, Monize Nakamoto Provisor Santos, Renan Valieris, Rodrigo Duarte Drummond, Alexandre Defelicibus, João Paulo Lima, Vinicius Fernando Calsavara, Helano Carioca Freitas, Vladmir C. Cordeiro de Lima, Thais Fernanda Bartelli, Marc Wiedner, Rafael Rosales, Kenneth John Gollob, Joanna Loizou, Emmanuel Dias-Neto, Diana Noronha Nunes, Israel Tojal da Silva. Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention. Cancers 2021; 13(3): 490 doi: 10.3390/cancers13030490
|
8 |
Supattra Chaithongyot, Phatcharida Jantaree, Olga Sokolova, Michael Naumann. NF-κB in Gastric Cancer Development and Therapy. Biomedicines 2021; 9(8): 870 doi: 10.3390/biomedicines9080870
|
9 |
Yanzhen Bi, Shanshan Li, Huixin Tang, Quanquan Wang, Quanyi Wang, Yonghong Yang, Xiaobei Zhang, Zhenfeng Shu, Zhongping Duan, Yu Chen, Feng Hong. A novel xenograft model of human hepatocellular carcinoma in immunocompetent mice based on the microcarrier-6. Transplant Immunology 2023; 76: 101738 doi: 10.1016/j.trim.2022.101738
|
10 |
Marek Majewski, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Ewelina Grywalska, Kamil Torres. Microbiota and the Immune System—Actors in the Gastric Cancer Story. Cancers 2022; 14(15): 3832 doi: 10.3390/cancers14153832
|
11 |
Jong Won Lee, Jae Sook Sung, Young Soo Park, Seok Chung, Yeul Hong Kim. Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells. Gastric Cancer 2019; 22(5): 967 doi: 10.1007/s10120-019-00935-x
|
12 |
Chi Xue, Yuwei Du, Yuegang Li, Huimian Xu, Zhi Zhu. Tumor budding as a predictor for prognosis and therapeutic response in gastric cancer: A mini review. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1003959
|
13 |
Yin Jin, Liping Tao, Shuqing Jin, Weiyang Cai. Patterns of immune infiltration in gastric cancer and their clinical significance. Japanese Journal of Clinical Oncology 2021; 51(7): 1067 doi: 10.1093/jjco/hyab054
|
14 |
Jiahua Xing, Yan Li, Youbai Chen, Yan Han. A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02726-8
|
15 |
Anna Junttila, Olli Helminen, Juha P. Väyrynen, Maarit Ahtiainen, Istvan Kenessey, Sirpa Jalkanen, Jukka-Pekka Mecklin, Ilmo Kellokumpu, Teijo Kuopio, Jan Böhm, Johanna Mrena. Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer. British Journal of Cancer 2020; 123(11): 1625 doi: 10.1038/s41416-020-01053-7
|
16 |
Hsi-Lung Hsieh, Ming-Chin Yu, Li-Ching Cheng, Mei-Yi Chu, Tzu-Hao Huang, Ta-Sen Yeh, Ming-Ming Tsai. Quercetin exerts anti-inflammatory effects<i> via</i> inhibiting tumor necrosis factor-α-induced matrix metalloproteinase-9 expression in normal human gastric epithelial cells. World Journal of Gastroenterology 2022; 28(11): 1139-1158 doi: 10.3748/wjg.v28.i11.1139
|
17 |
Mohammad Hossein Asghari, Milad Moloudizargari, Emad Ghobadi, Marjan Fallah, Mohammad Abdollahi. Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer. Life Sciences 2017; 185: 38 doi: 10.1016/j.lfs.2017.07.020
|
18 |
Qing Lv, Qinghua Xia, Anshu Li, Zhiyong Wang. The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/1533033821995282
|
19 |
Jose Francisco Islas, Adriana G. Quiroz-Reyes, Paulina Delgado-Gonzalez, Hector Franco-Villarreal, Juan Luis Delgado-Gallegos, Elsa N. Garza-Treviño, Carlos A. Gonzalez-Villarreal. Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum. Cancers 2022; 14(16): 3948 doi: 10.3390/cancers14163948
|
20 |
Ruochen Li, Heng Zhang, Yifan Cao, Xin Liu, Yifan Chen, Yangyang Qi, Jieti Wang, Kuan Yu, Chao Lin, Hao Liu, Hongyong He, He Li, Lingli Chen, Zhenbin Shen, Jing Qin, Weijuan Zhang, Yihong Sun, Jiejie Xu. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer. Cancer Immunology, Immunotherapy 2020; 69(7): 1327 doi: 10.1007/s00262-020-02550-7
|
21 |
Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen van de Vijver, M.V. Estrada, Paula I. Gonzalez-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G.G.M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nuciforo, Laura Comerma, E.A. Thompson, Sunil Lakhani, Seong-Rim Kim, Stuart Schnitt, Cecile Colpaert, Christos Sotiriou, Stefan J. Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frederique Penault-Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternes, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix-Triki, Mark van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph Sparano, David Rimm, Torsten Nielsen, Zuzana Kos, Stephen Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard-Gallo, Hugo M. Horlings, Leena Gandhi, Andre Moreira, Fred Hirsch, Maria V. Dieci, Maria Urbanowicz, Iva Brcic, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan W. Juco, Carsten Denkert, Jorge Reis-Filho, Sherene Loi, Stephen B. Fox. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Advances in Anatomic Pathology 2017; 24(6): 311 doi: 10.1097/PAP.0000000000000161
|
22 |
Marek Kos, Krzysztof Bojarski, Paulina Mertowska, Sebastian Mertowski, Piotr Tomaka, Łukasz Dziki, Ewelina Grywalska. New Horizons in the Diagnosis of Gastric Cancer: The Importance of Selected Toll-like Receptors in Immunopathogenesis Depending on the Stage, Clinical Subtype, and Gender of Newly Diagnosed Patients. International Journal of Molecular Sciences 2024; 25(17): 9264 doi: 10.3390/ijms25179264
|
23 |
Jun Xie, Liping Fu, Li Jin. Immunotherapy of gastric cancer: Past, future perspective and challenges. Pathology - Research and Practice 2021; 218: 153322 doi: 10.1016/j.prp.2020.153322
|
24 |
Marta Bonotto, Silvio Ken Garattini, Debora Basile, Elena Ongaro, Valentina Fanotto, Monica Cattaneo, Francesco Cortiula, Donatella Iacono, Giovanni Gerardo Cardellino, Nicoletta Pella, Gianpiero Fasola, Lorenzo Antonuzzo, Nicola Silvestris, Giuseppe Aprile. Immunotherapy for gastric cancers: emerging role and future perspectives. Expert Review of Clinical Pharmacology 2017; 10(6): 609 doi: 10.1080/17512433.2017.1313113
|
25 |
Marek Majewski, Kamil Torres, Paulina Mertowska, Sebastian Mertowski, Izabela Korona-Głowniak, Jan Korulczyk, Witold Zgodziński, Ewelina Grywalska. Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?. International Journal of Molecular Sciences 2023; 24(6): 5824 doi: 10.3390/ijms24065824
|
26 |
Gaoxuan Shao, Ying Liu, Lu Lu, Lei Wang, Guang Ji, Hanchen Xu. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. Journal of Ethnopharmacology 2024; 327: 117999 doi: 10.1016/j.jep.2024.117999
|
27 |
星辰 周. New Progress of Immunotherapy in Gastric Cancer. Advances in Clinical Medicine 2023; 13(03): 4904 doi: 10.12677/ACM.2023.133700
|